Stockscreener 앱 받기
0.6224
4.58%
-0.0326
Profusa Inc 주식(PFSA)의 최신 뉴스
What's going on with Profusa stock Tuesday? - MSN
Profusa’s Next-Generation Biosensor Technology: Real-Time Biochemistry Monitoring for Chronic Disease Management and Telemedicine Applications - Minichart
Profusa, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Profusa (NASDAQ: PFSA) outlines Lumee biosensor pipeline, funding and 1-for-75 reverse split - Stock Titan
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Profusa Amends Financing and Pursues PanOmics Acquisition - TipRanks
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Why did PFSA stock surge 80% pre-market today? - MSN
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Crude Oil Gains 3%; Alignment Healthcare Shares Jump - Sahm
Dow Falls 200 Points; US Durable Goods Orders Decline In February - Sahm
Gold Edges Higher; ISM Services PMI Falls In March - Sahm
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
What's Going On With Profusa Stock Tuesday? - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Profusa expands into precision diagnostics market - Medical Buyer
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform - bitget.com
Profusa to acquire multi-omics platform, partners with Mayo Clinic By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Monday's After-Market SessionAditxt (NASDAQ:ADTX), Advanced Biomed (NA - Benzinga
Monday's session: top gainers and losers - ChartMill
Why Did PFSA Stock Surge 150% Today? - Stocktwits
Curious about the most active stocks on Monday? - ChartMill
Profusa shares surge after $30M PanOmics acquisition LOI signals pivot into molecular diagnostics - Quiver Quantitative
Profusa (PFSA) Stock Soars 173% on $30M PanOmics Diagnostics Acquisition - Blockonomi
US Stocks Mixed; Nasdaq Gains Over 100 Points - Benzinga
Profusa (PFSA) Stock Rockets 173% After $30M Oncology Platform Deal - CoinCentral
Profusa’s Strategic Meeting Sparks Investment Talks - timothysykes.com
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Is Profusa Stock Soaring Monday?Profusa (NASDAQ:PFSA) - Benzinga
Profusa Inc. Signs $30 Million Non-Binding LOI to Acquire PanOmics Assets from Bio Insights LLC - Minichart
Profusa expands into multi-billion dollar precision diagnostics market with $30m letter of intent for a PanOmics platform - marketscreener.com
Profusa Expands Convertible Note Capacity to $12.22 Million, Issues $555,555 12% Note - TradingView
Profusa to acquire multi-omics platform, partners with Mayo Clinic - investing.com
Profusa (Nasdaq: PFSA) signs $30M PanOmics diagnostics LOI - Stock Titan
$Profusa (PFSA.US)$ tap in and out for a quick scalp - Moomoo
Profusa Expands into Multi-Billion Dollar Precision - GlobeNewswire
Trending Stocks Today | Profusa Soars 126.91% Pre-Market - Moomoo
Profusa, Inc. entered into a non-binding letter of intent to acquire Certain assets of Bio Insights LLC from Bio Insights LLC for $30 million. - marketscreener.com
PFSA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
NVACW SEC FilingsProfusa Inc 10-K, 10-Q, 8-K Forms - Stock Titan
PFSA Stock Chart | PROFUSA INC (NASDAQ:PFSA) - ChartMill
Profusa Delays Annual Report Amid Wider Losses - TipRanks
Profusa (NVACW) delays 2025 Form 10-K; $31.9M loss after merger - Stock Titan
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
PFSA Should I Buy - Intellectia AI
Profusa Incenters amendment to promissory note with Northview Sponsor I LLC on March 20, 2026SEC filing - marketscreener.com
Profusa Extends Promissory Note Maturity, Enhancing Liquidity - TipRanks
Profusa (NASDAQ: PFSA) pushes promissory note maturity to December 2026 - Stock Titan
Profusa outlines revenue plan, targets EU commercial launch of Lumee in early Q2 2026 - MSN
PFSA Technical Analysis | Trend, Signals & Chart Patterns | PROFUSA INC (NASDAQ:PFSA) - ChartMill
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Profusa (PFSA) Stock Forecast and Price Target 2026 - MarketBeat
0.13%
0.40%
자본화:
|
볼륨(24시간):